Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: PINE PHARMACEUTICALS LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-02-17 to 2024-02-16
Current total value of award: $44606.4
Description: NIDDK - ACQUISITION OF INTRAVENOUS STABLE ISOTOPE (D5 GLYCEROL, 6,6 D2-GLUCOSE) FOR METABOLIC RESEARCH